# Integra LifeSciences Cuts 2026 Guidance After Cincinnati Plant Flooding

- URL: https://stocks.freetheai.org/news/integra-lifesciences-cuts-2026-guidance-after-cincinnati-plant-flooding-9f7a1f
- Published: 2026-10-12T11:00:00Z
- Category: earnings; sentiment: bearish; impact: high
- Symbols: [NASDAQ:IART](https://stocks.freetheai.org/symbols/NASDAQ-IART)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Integra LifeSciences Holdings Corporation (NASDAQ:IART) reduced its full-year 2026 financial outlook following an operational disruption caused by flooding at its Cincinnati facility. The company now expects 2026 total revenue to range between $1.634 billion and $1.654 billion, while adjusted earnings per share are projected to land between $2.30 and $2.40.

The facility flood is expected to create a direct financial hit of $15 million to $20 million on fourth-quarter revenue. The unexpected update triggered a sharp market reaction, sending the stock down roughly 20% during intraday trading before shares partially recovered to $13.06. Most recently, the shares traded at $13.44.

Investors will monitor how effectively the company repairs its Cincinnati plant and manages fourth-quarter sales impacts. Future trading will depend on whether Integra LifeSciences can stabilize production and meet its updated full-year guidance targets.

## Key points

- Integra LifeSciences cut its 2026 revenue guidance to between $1.634 billion and $1.654 billion.
- Adjusted earnings per share for 2026 are now expected to be between $2.30 and $2.40.
- Flooding at the Cincinnati facility is projected to reduce fourth-quarter revenue by $15 million to $20 million.
- Shares plunged about 20% intraday following the news before making a partial recovery to $13.06.

## Questions and answers

### Why did Integra LifeSciences cut its 2026 financial guidance?

Integra LifeSciences lowered its outlook due to plant flooding in Cincinnati, which is expected to reduce fourth-quarter revenue by $15 million to $20 million.

### What is Integra LifeSciences updated 2026 revenue and EPS outlook?

The company expects 2026 total revenue between $1.634 billion and $1.654 billion, with adjusted earnings per share projected at $2.30 to $2.40.

### How did IART stock react to the guidance reduction?

IART stock dropped approximately 20% during intraday trading before making a partial recovery to trade near $13.06.